McGrath share price tanks as it warns Sydney's house prices are still falling

The McGrath Ltd (ASX:MEA) CEO is still worried about the outlook for Sydney's house prices.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The McGrath Ltd (ASX: MEA) share price hit a record low of 23 cents yesterday after the Sydney-focused real estate agency warned late on Friday that its full year EBITDA will balloon higher than previously forecast.

The CEO warned that for the eight months to 28 February 2019 the group made a $4.5 million EBITDA loss, with trading conditions in March 2019 also "below expectations".

McGrath also warned transaction volumes remain 20% below the prior year in both Sydney and Melbourne with Sydney home values down 10.4% on the prior year.

The group blamed the poor result on the federal and state elections creating uncertainties in NSW, alongside sellers failing to adjust the reality of the market in their price expectations.

Worryingly for McGrath and property bulls generally is the reality that the Reserve Bank now has little room to ease lending rates, with its cash rate already sitting at a historic low of 1.5%.

On the bright side the CEO did flag that McGrath's rentals business continues to perform well, while its balance sheet is in reasonable shape with no debt and $14.3 million in cash.

Elsewhere, real estate classifieds business REA Group Limited (ASX: REA) is also suffering a tough 2019 on the back of warnings over listing volumes falling in Melbourne and Sydney.

Motley Fool contributor Tom Richardson owns shares of REA Group Limited. You can find Tom on Twitter @tommyr345 The Motley Fool Australia has recommended REA Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Calculator and gold bars on Australian dollars, symbolising dividends.
Share Market News

Gold, silver hit new highs as US punishes Europe with tariffs over Greenland stance

The United States wants to buy Greenland for security purposes.

Read more »

Beautiful young woman drinking fresh orange juice in kitchen.
Share Gainers

Why Catalyst Metals, Lynas, Polynovo, and St George Mining shares are pushing higher today

These shares are starting the week with a bang. But why?

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why Fortescue, Life360, PLS, and Syrah shares are dropping today

These shares are starting the week in the red. But why?

Read more »

A few gold nullets sit on an old-fashioned gold scale, representing ASX gold shares.
Gold

Guess which surging ASX gold share is leaping another 18% today on high-grade results

Investors are piling into this small-cap ASX gold share today. But why?

Read more »

Green stock market graph with a rising arrow symbolising a rising share price.
Opinions

3 unstoppable ASX shares to buy with $3,000

These businesses have strong futures.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to buy these shares.

Read more »

A senior couple sets at a table looking at documents as a professional looking woman sits alongside them as if giving retirement and investing advice.
Share Market News

Nickel Industries posts Q4 earnings and lifts outlook

Nickel Industries reports lower December quarter EBITDA.

Read more »

a man sits at his desk wearing a business shirt and tie and has a hearty laugh at something on his mobile phone.
Share Market News

Neuren Pharmaceuticals revises DAYBUE revenue projections to reach US$700 million in 2028

Neuren Pharmaceuticals has projected DAYBUE global net sales to hit US$700 million by 2028.

Read more »